QUICKVUE INFLUENZA A+B— 510(k) K131619

Substantially Equivalent

Quidel Corp.

FDA 510(k) clearance K131619 for QUICKVUE INFLUENZA A+B, Substantially Equivalent on 2013-06-28. Applicant: Quidel Corp..

Clearance details

Applicant
Quidel Corp.
Product code
Code GNX
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.